ABOUT ATUM
ATUM is a fully integrated Californian based CRDO (Contract Research & Development Organization) biotechnology industry leader. ATUM, over the last two decades, has served life science researchers by delivering the highest quality services including but not limited to Gene Design and Gene Synthesis, Protein Engineering, Protein Production, Leap-In Transposase®, Cell Line Development, and Master Cell Banking (MCB). With a state-of-the-art machine learning platform, proprietary algorithms and thanks to its fully integrated Laboratory Information Management System (LIMS), ATUM takes you from virtual sequence to MCB with a click of a button. ATUM provides a continual commitment to innovation where services are built on bioengineered solutions to bring speed to market, supporting you from pre-clinical research through IND and beyond.
FEATURED PRODUCTS
VIDEOS AND WEBINARS
CONTACT INFORMATION
ATUM
37950 Central Court
Newark, CA 94560
UNITED STATES
Contact: Cheryl Sturgis
FEATURED ARTICLES
-
![ATUM feature Photo Jennifer Codding-Bui]( "Using GPS Engineering To Optimize Antibody-Based Drug Development")
Explore the results collected when a platform designed with ML-guided GPS engineering was applied to develop a lead molecule targeting a mechanism in neuronal disease.
-
![Microscope of cell, Embryonic stem cell]( "Leveraging Transposase Technologies To Optimize Cell Line Development")
Enable a wide array of genomic manipulation with the more regulated and efficient genomic insertion that's made possible by transposase-based technologies.
-
![GettyImages-958260280-genetic-engineering-genome-editing-helix-dna]( "What You Paste Matters")
Explore the use of transposase/transposon systems in the biotech industry, particularly in the development of stable cell lines for protein manufacturing.
-
![Cell & Gene Therapy Scientists GettyImages-1209892070]( "Engineering CHO K1 Cells With Three Orthogonal Transposase Systems")
Transposase-mediated genome engineering enables the robust and stable relocation of discrete DNA segments (transposons) in the genome, providing a valuable tool for stable transgene expression.
-
![ATUM hands]( "Obtain Proteins With Optimal Properties For Commercial Applications")
Tap into the vast diversity and potential of proteins found in nature using a unique protein platform based on Machine Learning and Design of Experiment.
-
![ATUM sar sequence]( "SAR – Sequence-Activity Relationships for Efficient Protein Engineering")
As protein-based therapeutics gain traction in the greater market, innovative techniques aimed at their optimization have become a key driver for industry.
-
![Atum use codon]( "Codon Optimization for Recombinant Protein Expression")
Despite our lack of understanding of the mechanistic forces behind sequence design for increased recombinant protein expression yield, a better, more tailored codon optimization paradigm is achievable.
-
![ATUM protein circle]( "Biotech Engineered To Meet Emergency Response Timelines")
Rapid antibody engineering and cell line development are vital in bringing therapies to clinics efficiently. Now, innovative technologies and communicative systems are making unrivaled speeds possible.
-
![ATUM covid]( "Rapid Generation Of Bulk-Selected CHO Pools")
Traditional cell line development is extremely time-consuming, taking up to six months and delaying the runway to clinical trials. However, innovative transposase technology offers a fast and robust alternative.
-
![ATUM Icon]( "What Provided Critical Reagents To The COVID-19 Pandemic Response?")
Typically, mAb manufacturing takes up to 60 days due to demand and outsourcing lags. Instead, imagine a unified platform that can deliver your mAb in 18 days.
-
![ATUM Transposase Frog]( "Build Your Genome Engineering Toolbox For Success")
Fast, efficient, and precise options for genome engineering are rapidly infiltrating the marketplace – the key to success is identifying the mechanism and tool(s) best suited for your goals.
